Risk of anaphylactic reaction associated with glatiramer acetate, used to treat ...
Reason for Recall / Hazard
Product safety - New safety information
Product Description & Identification
If you experience anaphylactic reaction symptoms, stop taking glatiramer acetate and seek immediate medical help by calling 9-1-1.Do not restart taking glatiramer acetate if you have experienced anaphylaxis unless your healthcare provider has identified another clear cause for the anaphylaxis.Report any health product-related side effects to Health Canada.What healthcare professionals should doInform patients and/or caregivers of the signs and symptoms of anaphylactic reactions, which may overlap with those of an immediate post-injection reaction.Instruct patients to seek immediate emergency medical care in the event of an anaphylactic reaction.Instruct patients to discontinue treatment with glatiramer acetate if they have an anaphylactic reaction.Do not restart the medicine unless there is another clear reason the patient experienced an anaphylactic reaction.
Affected Products
Glatiramer acetate
Additional Source Details
| Field | Value |
|---|---|
| N I D | 77939 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/risk-anaphylactic-reaction-associated-glatiramer-acetate-used-treat-multiple-sclerosis |
| Issue | Product safety - New safety information |
| Title | Risk of anaphylactic reaction associated with glatiramer acetate, used to treat multiple sclerosis |
| Product | Glatiramer acetate |
| Archived | 0 |
| Category | Drugs |
| Last updated | 2025-08-21 |
| Organization | Communications and Public Affairs Branch |
| What you should do | If you experience anaphylactic reaction symptoms, stop taking glatiramer acetate and seek immediate medical help by calling 9-1-1.Do not restart taking glatiramer acetate if you have experienced anaphylaxis unless your healthcare provider has identified another clear cause for the anaphylaxis.Report any health product-related side effects to Health Canada.What healthcare professionals should doInform patients and/or caregivers of the signs and symptoms of anaphylactic reactions, which may overlap with those of an immediate post-injection reaction.Instruct patients to seek immediate emergency medical care in the event of an anaphylactic reaction.Instruct patients to discontinue treatment with glatiramer acetate if they have an anaphylactic reaction.Do not restart the medicine unless there is another clear reason the patient experienced an anaphylactic reaction. |